Comparison Overview
FUJIFILM Biotechnologies

FUJIFILM Biotechnologies
101 J Morris Commons Lane, None, Morrisville, North Carolina, US, 27560
Last Update: 28/03/2026
For over 30 years, FUJIFILM Biotechnology’s mission has been advancing tomorrow’s medicine. As a CDMO, we work in partnership with the most innovative biopharma and biotech companies across the world who are reimagining healthcare’s potential. We help to accelerate thei...

Charles River Laboratories
251 Ballardvale Street, Wilmington, Massachusetts, US, 01887
Last Update: 31/03/2026
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of ou...
Compliance Ranges Comparison

FUJIFILM Biotechnologies







Charles River Laboratories






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for FUJIFILM Biotechnologies in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Charles River Laboratories in 2026.
Incident History - FUJIFILM Biotechnologies (X = Date, Y = Severity)
FUJIFILM Biotechnologies cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Charles River Laboratories (X = Date, Y = Severity)
Charles River Laboratories cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

FUJIFILM Biotechnologies

Charles River Laboratories
FAQ
Latest Global CVEs
Improper access control in Microsoft Edge for Android allows an unauthorized attacker to bypass a security feature over a network.
A security vulnerability has been detected in NousResearch hermes-agent up to 2026.4.30. Affected is the function GatewayStreamConsumer._filter_and_accumulate of the file gateway/stream_consumer.py of the component Streaming Reasoning Tag Filter. The manipulation leads to improper handling of case sensitivity. The attack may be initiated remotely. The attack's complexity is rated as high. The exploitability is told to be difficult. The exploit has been disclosed publicly and may be used. The project decided to not implement a dedicated fix: "[T]he analysis and the fix are both sound. It just lands below the bar for the maintenance cost of a duplicated scrub path."
- https://gist.github.com/YLChen-007/2229e5505bcbb3e15a7ae8fba4c4be37
- https://github.com/NousResearch/hermes-agent/
- https://github.com/NousResearch/hermes-agent/issues/27288
- https://github.com/NousResearch/hermes-agent/pull/28631#issuecomment-4622188016
- https://vuldb.com/cve/CVE-2026-14617
- https://vuldb.com/submit/844654
- https://vuldb.com/vuln/376134
- https://vuldb.com/vuln/376134/cti
Insufficient ui warning of dangerous operations in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.
Improper neutralization of input during web page generation ('cross-site scripting') in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.
Relative path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.